Drugs / Mixtard® 30
last change Jul 2021 re-read 2 minutes ago

Mixtard® 30

Developed for
type 2 diabetes mellitus

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT06855615 Comparator Oct 2020 → Jan 2021 type 2 diabetes mellitus Hospital Sultanah Aminah Johor Bahru Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Mixtard 30 ClinicalTrials.gov intervention name — accepted as the source's own label NCT06855615